Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9683-9697

  Laquerre, Sylvie ^a,b   Anderson, Dina B ^a   Stolz, Donna B ^a   Glorioso, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS ENVELOPE; VIRUS RECOMBINANT;

EID: 0031798089     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9683-9697.1998     Document Type: Article

References (91)

1. Banfield, B. W., Y. Leduc, L. Esford, K. Schubert, and F. Tufaro. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:3290-3298.
2. Bartz, S. R., and M. A. Vodicka. 1997. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis glycoprotein. Methods 12:337-342.
3. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
4. Butcher, M., K. Raviprakash, and H. P. Ghosh. 1990. Acid pH-induced fusion of cells by herpes simplex virus glycoproteins gB and gD. J. Biol. Chem. 265:5862-5868.
5. Cai, W., B. Gu, and S. Person. 1988. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:2596-2604.
6. Cai, W., S. Person, C. DebRoy, and B. Gu. 1988. Functional regions and stuctural features of the gB glycoprotein of herpes simplex virus type 1: an analysis of linker insertion mutants. J. Mol. Biol. 201:575-588.
7. Campadelli-Fiume, G., E. Avitabile, S. Fini, D. Stirpe, M. Arsenakis, and R. Roizman. 1988. Herpes simplex virus glycoprotein D is sufficient to induce spontaneous pH-independent fusion in a cell line that constitutively expresses the glycoprotein. Virology 166:598-602.
8. Carpenter, D. E., and J. G. Stevens. 1996. Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome. Hum. Gene Ther. 7:1447-1454.
9. Carter, V. C., S. R. Jennings, P. L. Rice, and S. S. Tevethia. 1984. Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes. J. Virol 49:766-771.
10. Cosset, F. L., and S. J. Russell. 1996. Targeting retrovirus entry. Gene Ther. 3:946-956.
11. Cruchley, A. T., D. M. Williams, G. Niedobitek, and L. S. Young. 1997. Epstein-Barr virus: biology and disease. Oral Dis. 3:S156-S163.
12. D'Andrea, A. D., H. F. Lodish, and G. G. Wong. 1989. Expression cloning of the murine erythropoietin receptor. Cell 57:277-285.
13. D'Andrea, A. D., J. F. Moreau, and M. O. Showers. 1992. Molecular mimicry of erythropoietin by the spleen focus-forming virus gp55 glycoprotein: the first stage of Friend virus-induced erythroleukemia. Biochim. Biophys. Acta 1114:31-41.
14. Desai, P., F. L. Homa, S. Person, and J. C. Glorioso. 1994. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses. Virology 204:312-322.
15. Digicaylioglu, M., S. Bichet, H. H. Marti, R. H. Wenger, L. A. Rovas, C. Bauer, and M. Gassmann. 1995. Localization of specific erythropoietin binding site in defined area of the mouse brain. Proc. Natl. Acad. Sci. USA 92:3717-3720.
16. Dingwell, K. S., C. R. Brunetti, R. L. Hendricks, Q. Tang, M. Tang, A. J. Rainbow, and D. C. Johnson. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68:834-845.
17. Dolter, K. E., S. R. King, and T. C. Holland. 1993. Incorporation of CD4 into virions by recombinant herpes simplex virus. J. Virol 67:189-195.
18. Dolter, K. E., W. F. Goins, M. Levine, and J. C. Glorioso. 1992. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J. Virol. 66:4864-4873.
19. Elliot, S., T. Lorenzini, D. Chang, J. Barzilay, and E. Delorme. 1997. Mapping of the active site of recombinant human erythropoietin. Blood 89:493-502.
20. Emi, N., T. Friedmann, and J. Yee. 1991. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65:1202-1207.
21. Fink, D. J., N. A. DeLuca, W. F. Goins, and J. C. Glorioso. 1996. Gene transfer to neurons using herpes simplex virus-based vectors. Annu. Rev. Neurosci. 19:265-287.
22. Fisher, J. W. 1997. Erythropoietin: physiologic and pharmacologic aspects. Proc. Soc. Exp. Biol. Med. 216:358-369.
23. Frink, R. J., R. J. Eisenberg, G. H. Cohen, and E. K. Wagner. 1983. Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J. Virol. 45:634-647.
24. Ghosh-Choudhury, N., M. Butcher, E. Reid, and H. P. Ghosh. 1994. Effect of tunicamycin and monensin on the transport to the cell surface and secrettion of a viral membrane glycoprotein containing both N- and O-linked sugars. Biochem. Cell Biol. 72:20-25.
25. Goins, W. F., D. Krisky, P. Marconi, T. Oligino, R. Ramakrishnan, P. L. Poliani, D. J. Fink, and J. C. Glorioso. 1997. Herpes simplex virus vectors for gene transfer to the nervous system. J. Neurovirol. 3:S80-S88.
26. Gruenheid, S., L. Gatzke, H. Meadows, and F. Tufaro. 1993. Herpes simplex virus infection and propagation in a mouse L-cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67:93-100.
27. Gunzburg, W. H., A. Fleuchaus, R. Saller, and B. Salmons. 1996. Retroviral vector targeting for gene therapy. Cytokines Mol. Ther. 3:177-184.
28. Harris, K. W., R. A. Mitchell, and J. C. Winkelmann. 1992. Ligand binding properties of the human erythropoietin receptor extracellular domain expressed in Escherichia coli. J. Biol. Chem. 267:15205-15209.
29. Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
30. Herold, B. C., R. J. Visalli, N. Sumarski, C. R. Brandt, and P. G. Spear. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B. J. Gen. Virol 75:1211-1222.
31. Highlander, S. L., S. L. Sutherland, P. J. Gage, D. C. Johnson, M. Levine, and J. C. Glorioso. 1987. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J. Virol. 61:3356-3364.
32. Holland, T. C., F. L. Homa, S. D. Marlin, M. Levine, and J. C. Glorioso. 1984. Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J. Virol. 52:566-574.
33. Horton, M. A., K. A. Larson, J. J. Lee, and N. A. Lee. 1996. Cloning of the murine eosinophil peroxidase gene (mEPO): characterization of a conserved subgroup of mammalian hematopoietic peroxidases. J. Leukoc. Biol. 60:285-294.
34. Johnson, D. L., F. X. Farrell, F. P. Barbone, F. J. McMahon, J. Tullai, K. Hoey, O. Livnah, N. C. Wrighton, S. A. Middleton, D. A. Loughney, E. A. Stura, W. J. Dower, L. S. Mulcahy, I. A. Wilson, and L. K. Jolliffe. 1998. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 37:3699-3710.
35. Kasahara, N., A. M. Dozy, and Y. W. Kan. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373-1376.
36. Kovesdi, I., D. E. Brough, J. T. Bruder, and T. J. Wickham. 1997. Adenovirus vector for gene transfer. Curr. Opin. Biotechnol. 8:583-589.
37. Koyoma, A. H., and A. Adachi. 1997. Induction of apoptosis by herpes simplex virus type 1. J. Gen. Virol. 78:2909-2912.
38. Krisky, D. M., P. C. Marconi, T. Oligino, R. J. Rouse, D. J. Fink, and J. C. Glorioso. 1997. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4:1120-1125.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
40. Laquerre, S., D. B. Anderson, R. Argnani, and J. C. Glorioso. 1998. Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing and incorporation into mature infectious virus particles. J. Virol. 72:4940-4949.
41. Laquerre, S., R. Argnani, D. B. Anderson, S. Zucchini, R. Manservigi, and J. C. Glorioso. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C differ in their contribution to virus attachment, penetration and cell-to-cell spread. J. Virol. 72:6119-6130.
42. Laquerre, S., W. F. Goins, S. Moriuchi, T. J. Oligino, D. M. Krisky, P. Marconi, M. K. Soares, J. B. Cohen, D. J. Fink, and J. C. Glorioso. Gene transfer tool: herpes simplex virus vector. In The development of human gene therapy, in press. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Li, J. P., H. O. Hu, Q. T. Niu, and C. Fang. 1995. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. J. Virol. 69:1714-1719.
44. Ligas, M. W., and D. C. Johnson. 1988. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62:1486-1494.
45. Lin, F.-K., S. Suggs, C.-H. Lin, J. K. Browne, R. Smalling, J. C. Egrie, K. K. Chen, G. M. Fox, F. Marlin, and Z. Wasser. 1985. Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 82:7850-7854.
46. Marconi, P., D. Krisky, T. Oligino, P. L. Poliani, R. Ramakrishnan, W. F. Goins, D. J. Fink, and J. C. Glorioso. 1996. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. USA 93:11319-11320.
47. Marin, M., D. Noel, S. Valsesia-Wittman, F. Brockly, M. Etienne-Julan, S. Russell, F. L. Cosset, and J. Piechaczyk. 1996. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. Virology 70:2957-2962.
48. Marlin, S. D., T. C. Holland, M. Levine, and J. C. Glorioso. 1985. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. J. Virol. 53:128-136.
49. Matthews, D. J., R. S. Topping, R. T. Cass, and L. B. Giebel. 1996. A sequential dimerization mechanism for erythropoietin receptor activation. Proc. Natl. Acad. Sci. USA 93:9471-9476.
50. McClain, D. S., and A. O. Fuller. 1994. Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. Virology 198:690-702.
51. Meignier, B., T. M. Jourdier, B. Norrild, L. Pereira, and B. Roizman. 1987. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus. J. Infect. Dis. 155:921-930.
52. Mettenleiter, T. C., and P. G. Spear. 1994. Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J. Virol. 68:500-504.
53. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
54. Nagata, Y., E. Nishida, and K. Todokoro. 1997. Activation of JNK signaling pathway by erythropoietin, thrombopoietin and interleukin-3. Blood 89:2664-2669.
55. Naldini, L., U. Blomer, P. Gallay, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
56. Narhi, L. O., K. H. Aoki, J. S. Philo, and T. Arakawa. 1997. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor. J. Protein Chem. 16:213-225.
57. Neda, H., C. H. Wu, and G. Y. Wu. 1991. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J. Biol. Chem. 266:14143-14146.
58. Ohno, K., K. Sawai, Y. Iijima, B. Levin, and D. Meruelo. 1997. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotechnol. 15:763-767.
59. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400-11406.
60. Philo, J. S., K. H. Aoki, T. Arakawa, L. O. Narhi, and J. Wen. 1996. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry 38: 1681-1691.
61. Rogers, B. E., J. T. Douglas, C. Ahlem, D. J. Buchsbaum, J. Frincke, and D. T. Curiel. 1997. Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther. 4:1387-1392.
62. Roizman, B., and A. E. Sears. 1996. Herpes simplex viruses and their replication, p. 2231-2295. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
63. Roop, C., L. Hutchinson, and D. C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:2285-2297.
64. Roux, P., P. Jeanteur, and M. Piechaczyk. 1989. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc. Natl. Acad. Sci. USA 86:9079-9083.
65. Russell, S. J., R. E. Hawkins, and G. Winter. 1993. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21:1081-1085.
66. Rux, A. H., W. T. More, J. D. Lambris, W. R. Abrams, C. Peng, H. M. Friedman, G. H. Cohen, and R. J. Eisenberg. 1996. Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J. Virol. 70:5455-5465.
67. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
68. Sawyer, S. T. 1990. Receptors for erythropoietin. Distribution, structure and role in receptor-mediated endocytosis in erythroid cells, p. 365-402. In M. Harris, Jr. (ed.), Blood cell biochemistry, vol. 1. Plenum Press, New York, N.Y.
69. Sears, A. E., B. S. McGwire, and B. Roizman. 1991. Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins. Proc. Natl. Acad. Sci. USA 88:5087-5091.
70. Seidel-Dugan, C., M. Ponce de Leon, H. M. Friedman, L. F. Fries, M. M. Frank, G. H. Cohen, and R. J. Eisenberg. 1988. C3b receptor activity on transfected cells expression glycoprotein C of herpes simplex virus types 1 and 2. J. Virol. 62:4027-4036.
71. Shieh, M.-T., D. WuDunn, R. I. Montgomery, J. D. Esko, and P. G. Spear. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1273-1281.
72. Sochanik, A., and S. Szala. 1996. On the strategy of using nonviral carriers in cancer gene therapy. Acta Biochim. Pol. 43:293-300.
73. Somia, N. V., M. Zoppe, and I. M. Verma. 1995. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc. Natl. Acad. Sci. USA 92:7570-7574.
74. Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180.
75. Stannard, L. M., A. O. Fuller, and P. G. Spear. 1987. Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J. Gen. Virol. 68:715-725.
76. Steiner, I., and P. G. J. Kennedy. 1995. Herpes simplex virus latent infection in the nervous system. Neurovirology 1:19-29.
77. Stevenson, M. 1997. Molecular mechanisms for the regulation of HIV replication, persistence and latency. AIDS 11:S25-S33.
78. Todokoro, K. Personal communication.
79. Trybala, E., T. Berghtröm, B. Svennerholm, S. Jeansson, J. C. Glorioso, and S. Olofsson. 1994. Localization of the functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulfate. J. Gen. Virol. 75:743-752.
80. Vile, R. G. 1998. Gene therapy. Curr. Biol. 8:R73-R75.
81. Vogel, V., H. J. Kramer, A. Backer, H. Meyer-Lehnert, W. Jelkmann, and J. Fandrey. 1997. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am. J. Hypertens. 10(3):289-296.
82. Whealy, M. E., A. K. Robbins, and L. W. Enquist. 1989. Replacement of the pseudorabies virus glycoprotein gIII gene with its postulated homolog, the glycoprotein gC gene of herpes simplex virus type 1. J. Virol. 63:4055-4059.
83. Wickham, T. J., M. E. Carrion, and I. Kovesdi. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:750-756.
84. Wickham, T. J., P. W. Roelvink, D. E. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparan containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1573.
85. Wickham, T. J., E. Tzeng, L. L. Shears II, P. W. Roelvink, Y. Li, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vivo gene transfer by adenovirus vector containing chimeric fiber proteins. J. Virol. 71:8221-8229.
86. Wrighton, N. C., F. X. Farrell, R. Chang, A. K. Kashyap, F. P. Barbone, L. S. Mulcahy, D. L. Johnson, R. W. Barrett, L. K. Jolliffe, and W. J. Dower. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-464.
87. Wu, C.-T. B., M. Levin, F. Homa, S. L. Highlander, and J. C. Glorioso. 1990. Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. J. Virol. 64:856-863.
88. Wu, N., S. C. Watkins, P. A. Schaffer, and N. A. DeLuca. 1996. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70:6358-6368.
89. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
90. Yang, Y., E. F. Vanin, M. A. Whitt, M. Fornerod, R. Zwart, R. D. Schneiderman, G. Grosveld, and A. W. Nienhuis. 1995. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 6:1203-1213.
91. Yee, J. K., T. Friedmann, and J. C. Burns. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:99-112.